This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
For example, a pharma company launching a new biosimilar for rheumatoid arthritis can publish a whitepaper detailing clinical comparisons with the branded biologic. Webinars & Virtual Conferences HCPs value expert insights and peer discussions. Medication trackers & digital health guides.
Add to that the competition from generics and biosimilars, and the stakes couldn’t be higher. For example, a campaign on “Managing Diabetes with XYZ Drug” can position your brand as a helpful resource. Using email, social media, in-person meetings, and webinars to deliver a consistent message across platforms.
This will help speed approval, increasing access to biosimilars while promoting safety and building confidence through strong post-market monitoring. The webinars will focus on unintended consequences that may result from the implementation of IRA provisions regarding biologic and biosimilar medicines.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content